Date of event
Continuing Education Credits
AASLD COVID-19 Clinical Oversight Subcommittee
AASLD Pediatric Liver Disorders SIG
North American Society for Pediatric Gastroenterology, Hepatology & Nutrition (NASPGHAN)
Society of Pediatric Liver Transplantation (SPLIT)
- Jaime Chu, MD
Icahn School of Medicine at Mount Sinai
- Mohit Kehar, MD
Queen’s University School of Medicine
- Noelle Ebel, MD
- Burnett "Beau" S. Kelly, MD
DCI Donor Services Inc.
- Nadia Ovchinsky, MD, MBA
Children's Hospital at Montefiore
- Emily R. Perito, MD, MAS
University of California, San Francisco
- Vicky Lee Ng, MD, FRCPC
Hospital for Sick Children
- Mercedes Martinez, MD
As the COVID-19 pandemic continues to evolve, it is important for the pediatric hepatology community to understand the liver manifestations in children with SARS-COV2 infection and Multi-System Inflammatory Syndrome in children (MIS-C). In addition, there may be unique susceptibilities in children with chronic liver disease and liver transplantation.
Participants will be able to:
- Understand liver involvement in SARS-COV2 infection and MIS-C
- Improve care for children with chronic liver disease and pediatric liver transplant recipients
- Develop strategies for safe re-entry to clinical practice in pediatric hepatology and transplantation
Jaime Chu, MD
Jaime Chu, MD is the Associate Chief in the Division of Pediatric Hepatology and Associate Professor of Pediatrics at the Icahn School of Medicine and the Recanati/Miller Transplantation Institute at Mount Sinai. Dr. Chu is a physician-scientist and runs an NIH-funded research group focused on metabolic regulation of liver fibrosis. Dr. Chu is a member of the AASLD COVID-19 Task Force and the AASLD COVID-19 Clinical Oversight subcommittee.
Mohit Kehar, MD
Dr. Mohit Kehar is a Pediatric Gastroenterologist and Hepatologist at Kingston Health Science Center, Ontario, Canada. He is an assistant professor in the Department of Pediatrics at Queens University. He is one of the principal investigators of the NASPGHAN/SPLIT COVID registry which was created to help understand the impact of COVID-19 in children with chronic liver disease and post-liver transplantation. His researches interests are in Pediatric Hepatology and Non-Alcoholic Fatty Liver Disease in children.
Noelle Ebel, MD
Dr. Noelle Ebel is the Director the Alagille Syndrome Program at Stanford University and serves on the Quality Improvement and Clinical Care (QICC) Committee, the Advocacy Committee for SPLIT and the Hepatology Committee for NASPGHAN. Dr. Ebel’s research interests are in long-term outcomes after liver transplantation with a recent publication on hepatic artery thrombosis utilizing the SPLIT database and on the heart-liver intersection with a recent publication on combined heart-liver transplantation.
Nadia Ovchinsky, MD, MBA
Nadia Ovchinsky, MD, MBA is the Director of Pediatric Hepatology, Medical Director of Pediatric Liver Transplantation, and an Associated Professor of Pediatrics at Albert Einstein College of Medicine - Children's Hospital at Montefiore. She trained in Pediatrics, Pediatric Gastroenterology, and Pediatric Hepatology at Columbia University Medical Center.
Dr. Ovchinsky’s research interests involve improving quality and enhancing the delivery care for children with chronic liver disorders, as well as optimizing long-term outcomes of pediatric liver transplantation. Dr. Ovchinsky is a member of Practice Metrics Committee, Vice Chair of Pediatric SIG Communications Committee, and a Pediatric SIG Liaison for NASPGHAN Professional Education Committee.
Emily R. Perito, MD, MAS
Emily R. Perito, MD, MAS is the Associate Medical Director of Pediatric Liver Transplant and an Associate Professor of Pediatrics and of Epidemiology and Biostatistics at the University of California, San Francisco. She is currently as Vice Chair of the United Network for Organ Sharing’s Pediatric Transplantation Committee and Vice Chair of the Society for Pediatric Liver Transplant Advocacy Committee.
Dr. Perito’s clinical and epidemiologic research focuses on optimizing outcomes for children with chronic liver disease and those waiting or after liver transplant. Within the AASLD, she is Chair of the Education Subcommitee for the Pediatric Liver Disorders Special Interest Group, a member of the Patient Engagement and Advocacy Committee for AASLD’s COVID-19 Task Force, and a member of the Clinical Research Committee.